Zheng Yongxiang 4
4 · NovaBay Pharmaceuticals, Inc. · Filed May 13, 2022
Insider Transaction Report
Form 4
Zheng Yongxiang
Director
Transactions
- Award
Restricted Stock Units
[F1]2022-05-11+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.
Signature
/s/ Justin Hall as attorney in fact for Yongxiang Zheng|2022-05-13